The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q
- 25 July 2000
- journal article
- case report
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (16) , 9168-9173
- https://doi.org/10.1073/pnas.150079597
Abstract
We have isolated the human GRAF gene (for GTPase regulator associated with the focal adhesion kinase pp125 FAK ). This gene was fused with MLL in a unique t(5;11)(q31;q23) that occurred in an infant with juvenile myelomonocytic leukemia. GRAF encodes a member of the Rho family of the GTPase-activating protein (GAP) family. On the protein level, it is 90% homologous to the recently described chicken GRAF gene that functions as a GAP of RhoA in vivo and is thus a critical component of the integrin signaling transduction pathway. The particular position of the human GRAF gene at 5q31 and the proposed antiproliferative and tumor suppressor properties of its avian homologue suggest that it also might be pathogenetically relevant for hematologic malignancies with deletions of 5q. To investigate this possibility, we sequenced 4–5 individual cDNA clones from 13 cases in which one allele of GRAF was deleted. We found point mutations within the GAP domain of the second GRAF allele in one patient. In two additional patients we found an insertion of 52 or 74 bp within the GRAF cDNA that generates a reading frame shift followed by a premature stop codon. GRAF maps outside the previously defined commonly deleted 5q31 region. Nevertheless, inactivation of both alleles in at least some cases suggests that deletions and mutations of the GRAF gene may be instrumental in the development and progression of hematopoeitic disorders with a del(5q).Keywords
This publication has 46 references indexed in Scilit:
- Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growthOncogene, 1999
- Ten novel 11q23 chromosomal partner sitesLeukemia, 1998
- Novel Genes Mapping to the Critical Region of the 5q− SyndromeGenomics, 1997
- 5q-, twenty-five years later: a SynopsisCancer Genetics and Cytogenetics, 1997
- The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivoNature Medicine, 1995
- An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G 1Science, 1995
- Molecular basis of IIq23 rearrangements in hematopoietic malignant proliferationsGenes, Chromosomes and Cancer, 1995
- Chromosomal translocations in human cancerNature, 1994
- Long PCRNature, 1994
- Molecular Mapping of Uncharacteristically Small 5q Deletions in Two Patients with the 5q- Syndrome: Delineation of the Critical Region on 5q and Identification of a 5q- BreakpointGenomics, 1994